/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
Nicolas GIRERD, MD, PhD, professor of Therapeutics, is a cardiologist and biostatistician currently director of the Nancy Plurithematic Clinical Investigation Center (CIC)-INSERM, France.
His current research interests are mainly focused on the quantification and treatment of congestion in acute and chronic heart failure. He is the author of over 300 publications in international journals (h-index>30).
He is the PI of studies focusing on congestion evaluation using lung ultrasound (p.e. AHF-CORE NCT03327532; AMBUSH NCT04741711) and is in steering committees of many academic randomized clinical trials in the field of heart failure and/or MRA therapy (p.e. EPURE TRANSPLANT NCT02490904; LEVOHEARTSHOCK NCT04020263; HYPO-ECMO NCT02754193 Levy Girerd JAMA 2022).
He developed the e’VM algorithm, using machine learning, that identify distinct phenotypes able to predict long-term heart failure risk (Kobayashi, Girerd, JACC imaging, 2021).
